Drug intelligence / Profile preview

XiLening

Development stage: Preclinical
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

**XiLening** is a named traditional Chinese medicine herbal preparation reported in clinical research for psychological disorders, including insomnia disorder, depressive disorder, and anxiety disorder. It was evaluated by Guang’anmen Hospital, China Academy of Chinese Medical Sciences, in a registered randomized parallel study of traditional Chinese medicine approaches for prevention and treatment of psychological diseases. Its constituent herbs, dosage form, route, and molecular mechanism have not been reliably identified in accessible public sources.

Other names: Xilening喜乐宁

Beyond the preview

Go deeper on XiLening.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XiLening.

Explore the full profile